Table 1.
Mesenchymal stem cells phenotypic characteristics
| Positive marker | Negative marker | Pluripotency | Ref. | ||
| ISCT criteria | Human MSC | CD73, CD90, CD105 | CD34, CD45, CD11b or CD14, CD19 or CD79α, HLA-DR | Osteogenic Chondrogenic Adipogenic | [38] |
| In AA experimental studies | Mouse BM-MSC | CD44, CD106, Sca-1 | CD11b, CD31, CD34, CD45, CD86, CD117 | Osteogenic Chondrogenic Adipogenic | [51,53] |
| Human placental-MSC | CD29, CD44, CD73, CD90, CD105 | CD14, CD19, CD34, CD45, HLA-DR | Data not shown | [54] | |
| Rat BM-MSC | CD44, CD73, CD90, CD105 | CD11b, CD45 | Data not shown | [56] | |
| Pig ASC | CD73, CD90, CD105 | CD14, CD11b | Osteogenic Chondrogenic Adipogenic | [57] | |
| Pig BM-MSC | CD13, CD29 | CD31, CD34, CD45 | Data not shown | [58] |
ISCT: International society of cell therapy; MSC: Mesenchymal stem cell; AA: Aortic aneurysm; BM-MSC: Bone marrow-derived MSC; HLA-DR: Human leukocyte antigen-DR; ASC: Adipose tissue-derived MSC.